Pharma & Biotech

After experiencing significant pressure earlier this year, biotechnology firm Xencor is demonstrating a notable resurgence. The company's equity has advanced...

Speculative investors in InnoCan Pharma received the news they've been anticipating, with groundbreaking research data potentially paving the way for...

Amicus Therapeutics has achieved a significant financial turning point, reporting its first GAAP-profitability alongside substantial revenue growth. The biotechnology firm's...

The competitive landscape for anti-obesity medications has been jolted by a significant development from Viking Therapeutics. The biopharmaceutical company announced...

The Danish pharmaceutical giant, once Europe's most valuable company, now faces a critical inflection point. In a dramatic strategic pivot,...

The biotech sector is known for its volatility, but Assembly Biosciences is currently demonstrating remarkable strength. Building on a year...

The animal health sector's leading company, Zoetis, finds itself mired in an extended decline. Market experts are systematically lowering their...

Healwell AI positions itself as a technological pioneer deploying artificial intelligence within the healthcare sector. However, this vision is currently...

The laboratory equipment giant finds itself navigating a classic market dilemma. While quarterly results have surpassed expectations and a massive...

A significant milestone has been reached by InnoCan Pharma, moving beyond speculative potential to deliver concrete scientific evidence. The recent...